世界における骨移植片/骨代用材の製品パイプライン動向2015...市場調査レポートについてご紹介

【英文タイトル】Bone Grafts and Substitutes - Pipeline Review, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 16
2 Introduction 17
2.1 Bone Grafts and Substitutes Overview 17
3 Products under Development 18
3.1 Bone Grafts and Substitutes – Pipeline Products by Stage of Development 18
3.2 Bone Grafts and Substitutes – Pipeline Products by Segment 19
3.3 Bone Grafts and Substitutes – Pipeline Products by Territory 20
3.4 Bone Grafts and Substitutes – Pipeline Products by Regulatory Path 21
3.5 Bone Grafts and Substitutes – Pipeline Products by Estimated Approval Date 22
3.6 Bone Grafts and Substitutes – Ongoing Clinical Trials 23
4 Bone Grafts and Substitutes – Pipeline Products under Development by Companies 24
4.1 Bone Grafts and Substitutes Companies – Pipeline Products by Stage of Development 24
4.2 Bone Grafts and Substitutes – Pipeline Products by Stage of Development 28
5 Bone Grafts and Substitutes Companies and Product Overview 32
5.1 aap Implantate AG Company Overview 32
5.1.1 aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview 32
5.2 Accelerated Orthopedic Technologies, Inc. Company Overview 35
5.2.1 Accelerated Orthopedic Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.3 Adaptaide Inc. Company Overview 36
5.3.1 Adaptaide Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.4 Adocia Company Overview 37
5.4.1 Adocia Pipeline Products & Ongoing Clinical Trials Overview 37
5.5 Advanced Biologics, LLC Company Overview 41
5.5.1 Advanced Biologics, LLC Pipeline Products & Ongoing Clinical Trials Overview 41
5.6 Agenta Biotechnologies, Inc. Company Overview 42
5.6.1 Agenta Biotechnologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.7 Allergan, Inc. Company Overview 43
5.7.1 Allergan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.8 Alphatec Holdings, Inc. Company Overview 46
5.8.1 Alphatec Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.9 Amedica Corporation Company Overview 48
5.9.1 Amedica Corporation Pipeline Products & Ongoing Clinical Trials Overview 48
5.10 Anika Therapeutics, Inc. Company Overview 50
5.10.1 Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.11 ApaTech Limited (Inactive) Company Overview 53
5.11.1 ApaTech Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 53
5.12 Aperion Biologics Corporation Company Overview 55
5.12.1 Aperion Biologics Corporation Pipeline Products & Ongoing Clinical Trials Overview 55
5.13 Arthro Kinetics AG Company Overview 62
5.13.1 Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 62
5.14 Aursos, Inc Company Overview 63
5.14.1 Aursos, Inc Pipeline Products & Ongoing Clinical Trials Overview 63
5.15 Berkeley Advanced Biomaterials, Inc. Company Overview 64
5.15.1 Berkeley Advanced Biomaterials, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.16 Bio2 Technologies, Inc. Company Overview 67
5.16.1 Bio2 Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.17 Bioactive Bone Substitutes Ltd. Company Overview 68
5.17.1 Bioactive Bone Substitutes Ltd. Pipeline Products & Ongoing Clinical Trials Overview 68
5.18 Bioregeneration Technologies, Inc Company Overview 69
5.18.1 Bioregeneration Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 69
5.19 Bio-Scaffold International Pte Ltd Company Overview 70
5.19.1 Bio-Scaffold International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 70
5.20 BioSET, Inc Company Overview 74
5.20.1 BioSET, Inc Pipeline Products & Ongoing Clinical Trials Overview 74
5.21 Bioventus LLC Company Overview 81
5.21.1 Bioventus LLC Pipeline Products & Ongoing Clinical Trials Overview 81
5.22 Body Organ Biomedical Corp. Company Overview 83
5.22.1 Body Organ Biomedical Corp. Pipeline Products & Ongoing Clinical Trials Overview 83
5.23 Bone Solutions, Inc. Company Overview 85
5.23.1 Bone Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
5.24 BoneGrafix, Inc. Company Overview 90
5.24.1 BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.25 BoneSupport AB Company Overview 91
5.25.1 BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview 91
5.26 Calcitec, Inc. Company Overview 95
5.26.1 Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.27 Cellright Technologies, LLC Company Overview 96
5.27.1 Cellright Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 96
5.28 CeraPedics, Inc. Company Overview 97
5.28.1 CeraPedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
5.29 Chinese University of Hong Kong Company Overview 104
5.29.1 Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 104
5.30 Citrics Biomedical, LLC Company Overview 105
5.30.1 Citrics Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview 105
5.31 CollPlant Ltd. Company Overview 106
5.31.1 CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview 106
5.32 ConMed Corporation Company Overview 108
5.32.1 ConMed Corporation Pipeline Products & Ongoing Clinical Trials Overview 108
5.33 CoreBone Ltd. Company Overview 110
5.33.1 CoreBone Ltd. Pipeline Products & Ongoing Clinical Trials Overview 110
5.34 ElutInc Company Overview 111
5.34.1 ElutInc Pipeline Products & Ongoing Clinical Trials Overview 111
5.35 EpiBone Company Overview 112
5.35.1 EpiBone Pipeline Products & Ongoing Clinical Trials Overview 112
5.36 Exactech, Inc. Company Overview 113
5.36.1 Exactech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 113
5.37 Graftoss Limited Company Overview 115
5.37.1 Graftoss Limited Pipeline Products & Ongoing Clinical Trials Overview 115
5.38 Graftys SAS Company Overview 116
5.38.1 Graftys SAS Pipeline Products & Ongoing Clinical Trials Overview 116
5.39 Inion Oy Company Overview 122
5.39.1 Inion Oy Pipeline Products & Ongoing Clinical Trials Overview 122
5.40 Innovia LLC Company Overview 123
5.40.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 123
5.41 Innovoss Inc. Company Overview 124
5.41.1 Innovoss Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
5.42 Integra LifeSciences Holdings Corporation Company Overview 125
5.42.1 Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview 125
5.43 ISTO Technologies, Inc. Company Overview 127
5.43.1 ISTO Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 127
5.44 Jellagen Pty Ltd Company Overview 128
5.44.1 Jellagen Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 128
5.45 kasios sas Company Overview 129
5.45.1 kasios sas Pipeline Products & Ongoing Clinical Trials Overview 129
5.46 Kensey Nash Corporation (Inactive) Company Overview 130
5.46.1 Kensey Nash Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 130
5.47 Kytogenics Pharmaceuticals, Inc. Company Overview 131
5.47.1 Kytogenics Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 131
5.48 Lacerta Technologies GmbH Company Overview 132
5.48.1 Lacerta Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 132
5.49 Mariel Therapeutics, Inc. Company Overview 134
5.49.1 Mariel Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 134
5.50 Maxigen Biotech Inc. Company Overview 135
5.50.1 Maxigen Biotech Inc. Pipeline Products & Ongoing Clinical Trials Overview 135
5.51 Medtronic plc Company Overview 138
5.51.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 138
5.52 Meta Biomed Co., Ltd. Company Overview 142
5.52.1 Meta Biomed Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 142
5.53 Miromatrix Medical Inc. Company Overview 144
5.53.1 Miromatrix Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 144
5.54 N2 Biomedical Company Overview 145
5.54.1 N2 Biomedical Pipeline Products & Ongoing Clinical Trials Overview 145
5.55 National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview 146
5.55.1 National Center of Innovation for Biomaterials in Orthopaedic Research Pipeline Products & Ongoing Clinical Trials Overview 146
5.56 Noraker Company Overview 147
5.56.1 Noraker Pipeline Products & Ongoing Clinical Trials Overview 147
5.57 NovaBone Products, LLC. Company Overview 149
5.57.1 NovaBone Products, LLC. Pipeline Products & Ongoing Clinical Trials Overview 149
5.58 Nutech Medical, Inc Company Overview 150
5.58.1 Nutech Medical, Inc Pipeline Products & Ongoing Clinical Trials Overview 150
5.59 NuVasive, Inc. Company Overview 151
5.59.1 NuVasive, Inc. Pipeline Products & Ongoing Clinical Trials Overview 151
5.60 Orthogen LLC Company Overview 155
5.60.1 Orthogen LLC Pipeline Products & Ongoing Clinical Trials Overview 155
5.61 OssiFi, Inc. Company Overview 156
5.61.1 OssiFi, Inc. Pipeline Products & Ongoing Clinical Trials Overview 156
5.62 OsteoNovus, LLC Company Overview 157
5.62.1 OsteoNovus, LLC Pipeline Products & Ongoing Clinical Trials Overview 157
5.63 PolyPid, Ltd. Company Overview 158
5.63.1 PolyPid, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 158
5.64 Promimic AB Company Overview 160
5.64.1 Promimic AB Pipeline Products & Ongoing Clinical Trials Overview 160
5.65 ReCaPP Company Overview 161
5.65.1 ReCaPP Pipeline Products & Ongoing Clinical Trials Overview 161
5.66 RepRegen Ltd. (Inactive) Company Overview 162
5.66.1 RepRegen Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 162
5.67 Revivicor, Inc. Company Overview 164
5.67.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 164
5.68 RTI Surgical, Inc. Company Overview 166
5.68.1 RTI Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 166
5.69 Sanofi Company Overview 168
5.69.1 Sanofi Pipeline Products & Ongoing Clinical Trials Overview 168
5.70 SIRAKOSS Limited Company Overview 170
5.70.1 SIRAKOSS Limited Pipeline Products & Ongoing Clinical Trials Overview 170
5.71 Soft Tissue Regeneration, Inc. Company Overview 171
5.71.1 Soft Tissue Regeneration, Inc. Pipeline Products & Ongoing Clinical Trials Overview 171
5.72 Soteira Inc. Company Overview 175
5.72.1 Soteira Inc. Pipeline Products & Ongoing Clinical Trials Overview 175
5.73 Spineway Company Overview 176
5.73.1 Spineway Pipeline Products & Ongoing Clinical Trials Overview 176
5.74 SurgaColl Technologies Ltd Company Overview 178
5.74.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 178
5.75 TBF Genie Tissulaire Company Overview 181
5.75.1 TBF Genie Tissulaire Pipeline Products & Ongoing Clinical Trials Overview 181
5.76 The Johns Hopkins University Company Overview 183
5.76.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 183
5.77 Tissue Regeneration Systems, Inc. Company Overview 184
5.77.1 Tissue Regeneration Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.78 Trinity College Dublin Company Overview 185
5.78.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 185
5.79 University of California, San Diego Company Overview 186
5.79.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 186
5.80 University of Edinburgh Company Overview 187
5.80.1 University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 187
5.81 University of Memphis Company Overview 189
5.81.1 University of Memphis Pipeline Products & Ongoing Clinical Trials Overview 189
5.82 University of Nottingham’s School Of Pharmacy Company Overview 190
5.82.1 University of Nottingham’s School Of Pharmacy Pipeline Products & Ongoing Clinical Trials Overview 190
5.83 University of Pecs Company Overview 191
5.83.1 University of Pecs Pipeline Products & Ongoing Clinical Trials Overview 191
5.84 University of South Florida Company Overview 192
5.84.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 192
5.85 Wayne State University Company Overview 193
5.85.1 Wayne State University Pipeline Products & Ongoing Clinical Trials Overview 193
5.86 Wound Management Technologies, Inc. Company Overview 194
5.86.1 Wound Management Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 194
5.87 Wright Medical Group, Inc. Company Overview 196
5.87.1 Wright Medical Group, Inc. Pipeline Products & Ongoing Clinical Trials Overview 196
5.88 X-spine Systems, Inc. Company Overview 203
5.88.1 X-spine Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 203
5.89 Xtant Medical Holdings, Inc. Company Overview 204
5.89.1 Xtant Medical Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 204
6 Bone Grafts and Substitutes- Recent Developments 207
7 Appendix 267
7.1 Methodology 267
7.2 About GlobalData 269
7.3 Contact Us 270
7.4 Disclaimer 270


【レポート販売概要】

■ タイトル:世界における骨移植片/骨代用材の製品パイプライン動向2015
■ 英文:Bone Grafts and Substitutes - Pipeline Review, 2015
■ 発行日:2015年10月1日
■ 調査会社:GlobalData
■ 商品コード:GDME0079EPD
■ 調査対象地域:グローバル
  • 航空用材料の世界市場:アルミ合金、合金鋼、チタン合金、超合金、複合材料
    Aerospace materials are those materials used by the aircraft manufacturers and OEMs for building various aircraft parts. They use various materials such as aluminum alloys, steel alloys, titanium alloys, super alloys and composite materials. Composite materials in aerospace are used primarily because they have higher strength to weight ratio than metals. Thus, they help save a fuel thereby decreas …
  • 世界のアウトドア服市場動向
    “Outdoor is a metaphor for freedom, adventure, adrenalin, extraversion, creativity, dynamism, and personal power.” Mike Lipkin, president of Lipkin/Environics Report extract: Outdoor brands have benefitted from the overall casualisation of apparel, while maintaining a “cool” factor based on an implied lifestyle of adventure, leisure, and sport. The pricing of high-end technical apparel makes these …
  • 世界のTOCアナライザー市場:種類別、地域別
    Global TOC Analyzer Market: About this market Technavio’s TOC analyzer market analysis considers sales from both laboratory and online types. Our study also finds the sales of TOC analyzers in Asia, Europe, North America, and ROW. In 2019, the laboratory segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as cost-effectiveness will …
  • ピコ・プロジェクターの世界市場2015-2019
    About Pico Projector A projector is a portable optical device that projects images on any surface or screen. Traditional projector and pico projector are the two types of projector available; the latter is preferred over the former for its small size, light weight, and easy portability. There are two types of pico projector available in the market: standalone and embedded. Technavio's analysts for …
  • 地上支援装置(GSE)の世界市場:乗客、貨物、航空機
    The global ground support equipment (GSE) market has been estimated to be worth USD 12.22 Billion in 2016, and is projected to reach USD 19.44 Billion by 2021, at a CAGR of 9.72%. Some of the key drivers for the growth of the ground support equipment market include rise in air traffic and increasing focus by airports towards enhancing their operational efficiency. The outsourcing of maintenance, r …
  • 世界のPDM (製品データ管理)ソフトウェア市場
    About PDM PDM is one of the business functions within collaborative product definition management (cPDM), which is one of the major segments in the Global Product Lifecycle Management (PLM) market. PDM is a software responsible for the creation, management, and publication of product data. PDM helps organize product development by combining documents, technical data, computer-aided design (CAD), a …
  • OraSure Technologies, Inc.:市場シェア分析
    OraSure Technologies, Inc. Market Share Analysis Summary GlobalData’s new report, “OraSure Technologies, Inc. Market Share Analysis” provides in-depth information on OraSure Technologies, Inc.’s market position in the different medical equipment markets it operates in. The report provides OraSure Technologies, Inc. market share information in one key market category – Infectious Immunology. The re …
  • 世界の交通管理市場:ソリューション、ディスプレイ、システム
    The traffic management report consists of market opportunity, analysis of technology adoption in systems, solutions, detections, and displays market. The report explores some of the major sub-segments of solutions market: Extra Low Voltage (ELV) solutions, intersection controllers, full pedestrian solutions, LED signals retrofit solutions and parking space and ticketing management solutions; detec …
  • ヘルニア修復:企業と競争環境
    MediPoint: Hernia Repair - Current and Future Players Summary Dramatic improvements in access to and quality of healthcare in the Asia Pacific region, concurrent with the introduction of next-generation biologic and composite meshes in developed countries and adoption of laparoscopic techniques worldwide, will drive hernia repair market growth in the US, Europe and Asia Pacific. Saturated with num …
  • デジタル印刷の世界市場予測(~2023年):プリンタ、インキ、プリントヘッド
    According to MarketsandMarkets’ forecast, the digital printing market, in terms of value, is expected to grow from USD 22.18 Billion in 2017 to USD 28.85 Billion by 2023, at a CAGR of 4.48% between 2017 and 2023. Major drivers for the market are the growing demand for sustainable printing, development of packaging and textile industries, and reduction in per unit cost of printing with digital prin …
  • 政府向け生体認証システムの世界市場:地域別分析
    Summary This report offers detailed analysis of the global Government Biometric Systems market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Government Biometric Systems market. Key Findings "The Global Government Biometric Systems Market 2015-2025 - Country Analysis: Market Profile" provide …
  • 重要インフラ防護(CIP)の世界市場予測2016-2026
    Our new study reveals trends, market progress, and predicted revenuesWhere is the CIP market heading? If you are involved in the critical infrastructure protection sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2026, assessing data, trends, opportunities and business prospects there. Discover How to Stay Ahead Our 378 page report provide …
  • BDaaS(Big Data as a Service)の世界市場予測
    Today, there is a tremendous increase of unstructured data across various verticals, such as Banking, Financial Services and Insurance (BFSI), healthcare and life sciences, retails and consumer goods, manufacturing, travel and hospitality, IT and telecommunication, media and entertainment, government, and others. Big data analytics has become the need of the hour for these industries in order to g …
  • 人工肛門用パウチの世界市場2016-2020
    About the Colostomy Bags Market An ostomy procedure, both temporary and permanent depending on the type of condition, involves the surgical creation of an opening or stoma in the human body to excrete waste products such as feces, mucus, and urine. Ostomy products include ostomy bags or pouches and ostomy care accessories. Ostomy bags are placed outside the patient's body to collect waste. Ostomy …
  • ストラッピングマシンの世界市場2019-2023
    About this market The rise in global containerized cargo trade is one of the key factors expected to trigger the strapping machine market growth in the forthcoming years. Companies are purchasing packaging equipment including strapping machines for facilitating the smooth transportation of containerized goods. Furthermore, the rising number of trade agreements among several economies is also incre …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。